Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 784,728 | -- | 1,772,915 |
Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 784,728 | -- | 1,772,915 |
Apr 01, 2021 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 775,000 | -- | 775,000 |
Aug 23, 2018 |
Ten Percent Owner
Trans History: 12
|
Ten Percent Owner | Form 4 | Conversion of derivative security | 637,984 | -- | 988,187 |
Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 637,984 | -- | 988,187 |
Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 637,984 | -- | 988,187 |
Aug 23, 2018 |
Ten Percent Owner
Trans History: 20
|
Ten Percent Owner | Form 4 | Conversion of derivative security | 591,184 | -- | 591,184 |
Feb 15, 2023 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 560,000 | -- | 560,000 |
Feb 15, 2023 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 560,000 | -- | 560,000 |
Feb 15, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 490,000 | -- | 490,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.